Synthesis of N-Hydroxycinnamides Capped with a Naturally Occurring Moiety as Inhibitors of Histone Deacetylase
碩士 === 臺北醫學大學 === 生藥學研究所 === 98 === Histone deacetylase (HDAC) inhibitors are regarded as promising therapeutics for the treatment of cancer. All reported HDAC inhibitors contain three pharmacophoric features: a zinc-chelating group, a hydrophobic linker, and a hydrophobic cap for surface recognitio...
Main Authors: | Shih-Wei Chao, 趙世偉 |
---|---|
Other Authors: | Wei-Jan Huang |
Format: | Others |
Language: | zh-TW |
Published: |
2010
|
Online Access: | http://ndltd.ncl.edu.tw/handle/99843268828680284580 |
Similar Items
-
I.Aliphatic Hydroxamates Capped with Substituted Aryl Indole as Histone Deacetylase InhibitorsII.Structure Optimization for Ortho-Aryl N-Hydroxycinnamides as HDAC 8 Isoform-Selective Inhibitors against Cancer CellsII.Structure Optimization forOrtho-Aryl N-Hydroxycinnamides as
by: Wen-Yang Wang, et al.
Published: (2014) -
Target Design of Novel Histone Deacetylase 6 Selective Inhibitors with 2‐Mercaptoquinazolinone as the Cap Moiety
by: Bui, H.T.B, et al.
Published: (2022) -
Target Design of Novel Histone Deacetylase 6 Selective Inhibitors with 2‐Mercaptoquinazolinone as the Cap Moiety
by: Bui, H.T.B, et al.
Published: (2022) -
Synthesis of inhibitors of histone deacetylase
by: Dines, J.
Published: (2008) -
Discovery of potent histone deacetylase inhibitors with modified phenanthridine caps
by: Wenli Fan, et al.
Published: (2021-01-01)